Related Experiment Video
Updated: Aug 13, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function
J P Cogswell1, C E Brown, J E Bisi
1Department of Functional Genetics, Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA. jpc30240@glaxowellcome.com
Abstract:
Polo-like kinase 1 (PLK1), which has been shown to have a critical role in mitosis, is one possible target for cancer therapeutic intervention. PLK1, at least in Xenopus, starts the mitotic cascade by phosphorylating and activating cdc25C phosphatase. Also, loss of PLK1 function has been shown to induce mitotic catastrophe in a HeLa cervical carcinoma cell line but not in normal Hs68 fibroblasts. We wanted to understand whether the selective mitotic catastrophe in HeLa cells could be extended to other tumor types, and, if so, whether it could be attributable to a tumor-specific loss of dependence on PLK1 for cdc25C activation. When PLK1 function was blocked through adenovirus delivery of a dominant-negative gene, we observed tumor-selective apoptosis in most tumor cell lines. In some lines, dominant-negative PLK1 induced a mitotic catastrophe similar to that published in HeLa cells (K. E. Mundt et al., Biochem. Biophys Res. Commun., 239: 377-385, 1997). Normal human mammary epithelial cells, although arrested in mitosis, appeared to escape the loss of centrosome maturation and mitotic catastrophe seen in tumor lines. Mitotic phosphorylation of cdc25C and activation of cdk1 was blocked by dominant-negative PLK1 in human mammary epithelial cells as well as in the tumor lines regardless of whether they underwent mitotic catastrophe. These data strongly argue that the mitotic catastrophe is not attributable to a lack of dependence for PLK1 in activating cdc25C.
Insights
Polo-like kinase 1 (PLK1) inhibition causes tumor cell death, not normal cells. This selective cancer cell apoptosis is not due to tumor cells being more dependent on PLK1 for mitotic progression.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Therapeutics
Background:
- Polo-like kinase 1 (PLK1) is crucial for mitosis and a potential cancer therapeutic target.
- PLK1 initiates the mitotic cascade by activating cdc25C phosphatase.
- Loss of PLK1 function induces mitotic catastrophe selectively in cancer cells (HeLa) but not normal cells (Hs68).
Purpose of the Study:
- To investigate if selective mitotic catastrophe induced by PLK1 inhibition extends to other tumor types.
- To determine if this selectivity is due to tumor-specific dependence on PLK1 for cdc25C activation.
Main Methods:
- Adenovirus-mediated delivery of a dominant-negative PLK1 gene to block PLK1 function.
- Comparison of cellular responses (apoptosis, mitotic catastrophe) in various tumor cell lines and normal human mammary epithelial cells.
- Assessment of cdc25C phosphorylation and cdk1 activation.
Main Results:
- Dominant-negative PLK1 induced tumor-selective apoptosis in most tested tumor cell lines.
- Mitotic catastrophe, similar to HeLa cells, occurred in some tumor lines but not in normal human mammary epithelial cells.
- Normal cells arrested in mitosis but escaped catastrophic events like centrosome maturation loss.
- PLK1 inhibition blocked cdc25C phosphorylation and cdk1 activation in both tumor and normal cells.
Conclusions:
- The observed tumor-selective mitotic catastrophe is not caused by a lack of tumor cell dependence on PLK1 for cdc25C activation.
- PLK1 inhibition represents a promising strategy for selective cancer therapy, inducing apoptosis in tumor cells while sparing normal cells.
Related Concept Videos
Positive Regulator Molecules
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex

